tibolone has been researched along with Thromboembolism in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (90.91) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, R; Griffin, JC; Humphrey, L; Nelson, HD; Nygren, P; Smith, ME | 1 |
| Biglia, N; Lello, S; Maffei, S; Nappi, RE | 1 |
| Szántó, F | 1 |
| Kelly, MW; Swegle, JM | 1 |
| Burger, HG | 1 |
| Andersen, TO; Eilertsen, AL; Qvigstad, E; Sandset, PM; Sandvik, L | 1 |
| Kimmig, R; Schmidt, M | 1 |
| Jespersen, J; Nilas, L; Sidelmann, JJ; Skouby, SO | 1 |
| Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM | 1 |
| Alexandrou, AP; Bastounis, E; Bramis, J; Christodoulakos, GE; Creatsas, GC; Dalamanga, A; Keramaris, NC; Lambrinoudaki, IV | 1 |
| Altkemper, R; Coelingh Bennink, HJ; Helmond, FA; Kwee, B; Winkler, UH | 1 |
5 review(s) available for tibolone and Thromboembolism
| Article | Year |
|---|---|
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.
Topics: Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Fractures, Bone; Humans; Norpregnenes; Raloxifene Hydrochloride; Stroke; Tamoxifen; Thromboembolism | 2009 |
Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
Topics: Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Myocardial Infarction; Norpregnenes; Postmenopause; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Thromboembolism | 2010 |
Tibolone: a unique version of hormone replacement therapy.
Topics: Breast Neoplasms; Cardiovascular System; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Thromboembolism | 2004 |
Hormone therapy in the WHI era.
Topics: Aged; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Forecasting; Humans; Menopause; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Risk Assessment; Thromboembolism; Victoria; Women's Health | 2006 |
[The benefits and risks of hormonal replacement therapy--an update].
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Dementia; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Meta-Analysis as Topic; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Primary Prevention; Progestins; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Time Factors | 2006 |
4 trial(s) available for tibolone and Thromboembolism
| Article | Year |
|---|---|
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation.
Topics: Antineoplastic Agents, Hormonal; Blood Coagulation; Blood Coagulation Tests; Bone Density Conservation Agents; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboembolism | 2006 |
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis | 2007 |
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism; Venous Thrombosis | 2007 |
Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study.
Topics: Aged; Blood Coagulation; Blood Coagulation Tests; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Fibrinolysis; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism | 2000 |
2 other study(ies) available for tibolone and Thromboembolism
| Article | Year |
|---|---|
[Tibolone therapy in postmenopausal women with a history of many risk factors].
Topics: Cardiovascular Diseases; Diabetes Complications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Hypertension; Middle Aged; Norpregnenes; Postmenopause; Risk Factors; Stroke; Thromboembolism | 2003 |
A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
Topics: Aged; Animals; Blood Coagulation; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hemostasis; Horses; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Thromboembolism; Venous Thrombosis | 2007 |